吸烟与动脉瘤性蛛网膜下腔出血后的结局:一项全国性分析
基于美国全国住院患者样本(NIS,2009-2011)的5784例动脉瘤性蛛网膜下腔出血修复患者分析显示,吸烟者较不吸烟者更年轻且合并症更多,但在气管切开或胃造瘘放置、出院至机构照护及不良结局方面调整后比值比更低,死亡率和总并发症无显著差异,作者指出需进一步研究确认这一矛盾性关联。
要点
- 吸烟者发生动脉瘤性蛛网膜下腔出血时更年轻(平均51.4岁 vs 56.2岁)且合并症更多(p<0.001)。
- 吸烟者气管切开或胃造瘘放置率更低(11.9% vs 22.7%,OR 0.63,95%CI 0.51-0.78,p<0.001)。
- 吸烟与出院至机构照护(OR 0.71,95%CI 0.57-0.89,p=0.002)和不良结局(OR 0.65,95%CI 0.55-0.77,p<0.001)的调整后比值比降低相关。
核心结论
- 吸烟者发生动脉瘤性蛛网膜下腔出血时更年轻且合并症更多,凸显吸烟对脑动脉瘤患者的负面影响。
- 吸烟同时与部分指标上矛盾的更优结局相关,需要未来研究确认并进一步理解这一关系的基础。
研究设计与样本
- 从全国住院患者样本(NIS,2009-2011)中提取接受血管内或显微外科修复破裂脑动脉瘤的患者,按吸烟状态分层。
- 采用多变量logistic回归分析院内死亡、并发症、气管切开或胃造瘘放置及出院至机构照护,并评估复合NIS-SAH结局指标。
- 回归协变量包括年龄、性别、种族/民族、保险状态、社会经济状态、合并症(含高血压、药物和酒精滥用)、NIS-SAH严重程度量表、动脉瘤修复方式及医院特征。
- 进行敏感性分析,按年龄、性别、合并症数量和NIS-SAH严重程度量表评分将吸烟者与不吸烟者匹配。
主要发现
- 共评估5784例入院,37.1%(n=2148)有烟草使用诊断,其中31.1%(n=1800)为当前吸烟者,6.0%(n=348)为既往吸烟者。
- 吸烟者显著更年轻(平均年龄51.4岁 vs 56.2岁)且合并症更多(p<0.001)。
- 吸烟状态在死亡率、总并发症或神经系统并发症方面无显著差异。
- 与不吸烟者相比,吸烟者气管切开或胃造瘘放置的调整后比值比显著降低(11.9% vs 22.7%,OR 0.63,95%CI 0.51-0.78,p<0.001)。
- 吸烟者出院至机构照护(OR 0.71,95%CI 0.57-0.89,p=0.002)和不良结局(OR 0.65,95%CI 0.55-0.77,p<0.001)的调整后比值比显著降低。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE Although cigarette smoking is one of the strongest risk factors for cerebral aneurysm development and rupture, there are limited data evaluating the impact of smoking on outcomes after aneurysmal subarachnoid hemorrhage (SAH). Additionally, two recent studies suggested that nicotine replacement therapy was associated with improved neurological outcomes among smokers who had sustained an SAH compared with smokers who did not receive nicotine. METHODS Patients who underwent endovascular or microsurgical repair of a ruptured cerebral aneurysm were extracted from the Nationwide Inpatient Sample (NIS, 2009-2011) and stratified by cigarette smoking. Multivariable logistic regression analyzed in-hospital mortality, complications, tracheostomy or gastrostomy placement, and discharge to institutional care (a nursing or an extended care facility). Additionally, the composite NIS-SAH outcome measure (based on mortality, tracheostomy or gastrostomy, and discharge disposition) was evaluated, which has been shown to have excellent agreement with a modified Rankin Scale score greater than 3. Covariates included in regression constructs were patient age, sex, race/ethnicity, insurance status, socioeconomic status, comorbidities (including hypertension, drug and alcohol abuse), the NIS-SAH severity scale (previously validated against the Hunt and Hess grade), treatment modality used for aneurysm repair, and hospital characteristics. A sensitivity analysis was performed matching smokers to nonsmokers on age, sex, number of comorbidities, and NIS-SAH severity scale score. RESULTS Among the 5784 admissions evaluated, 37.1% (n = 2148) had a diagnosis of tobacco use, of which 31.1% (n = 1800) were current and 6.0% (n = 348) prior tobacco users. Smokers were significantly younger (mean age 51.4 vs 56.2 years) and had more comorbidities compared with nonsmokers (p < 0.001). There were no significant differences in mortality, total complications, or neurological complications by smoking status. However, compared with nonsmokers, smokers had significantly decreased adjusted odds of tracheostomy or gastrostomy placement (11.9% vs 22.7%, odds ratio [OR] 0.63, 95% confidence interval [CI] 0.51-0.78, p < 0.001), discharge to institutional care (OR 0.71, 95% CI 0.57-0.89, p = 0.002), and a poor outcome (OR 0.65, 95% CI 0.55-0.77, p < 0.001). Similar statistical associations were noted in the matched-pairs sensitivity analysis and in a subgroup of poor-grade patients (the upper quartile of the NIS-SAH severity scale). CONCLUSIONS In this nationwide study, smokers experienced SAH at a younger age and had a greater number of comorbidities compared with nonsmokers, highlighting the negative ramifications of cigarette smoking among patients with cerebral aneurysms. However, smoking was also associated with paradoxical superior outcomes on some measures, and future research to confirm and further understand the basis of this relationship is needed.
引用
- Dasenbrock HH, Rudy RF, Rosalind Lai PM, et al. Cigarette smoking and outcomes after aneurysmal subarachnoid hemorrhage: a nationwide analysis. J Neurosurg. 2017. PMID: 29076779. doi:10.3171/2016.10.JNS16748
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。